MRSH stock forecast, quote, news & analysis

Key Takeaways

• MRSH shares declined roughly 11.5% over the past 30 days, slipping from about $193 to near $171 per share.
• The pullback came despite a strong second-quarter 2026 earnings report, reflecting softer insurance and reinsurance pricing and valuation concerns.
• Over the trailing quarter, the stock is essentially flat after rallying to a peak near $198 in late July and then reversing lower.
• Q2 2026 results showed 6% revenue growth and 9% adjusted EPS growth, but rising expenses and margin pressure weighed on sentiment.
• Investors are now watching third-quarter earnings on October 15, 2026, along with pricing trends and the company's efficiency program.

Marsh (MRSH) Company Overview and Market Position

Marsh (NYSE: MRSH), formerly Marsh & McLennan Companies, is a global professional services leader in risk, reinsurance and capital, people and investments, and management consulting. The firm adopted the "Marsh" brand and changed its ticker from MMC to MRSH in January 2026. It advises clients in 130 countries, generates roughly $27 billion in annual revenue, and employs more than 95,000 colleagues.

The company operates through four core businesses: Marsh (insurance broking and risk advisory), Guy Carpenter (reinsurance broking), Mercer (health, wealth, and career consulting), and Marsh Management Consulting, which includes the Oliver Wyman franchise. Its diversified, largely fee-based model produces resilient cash flow that supports a long-running dividend growth track record, with 17 consecutive years of payout increases. Investors follow the stock for its exposure to global insurance and consulting demand, its AI and technology investments, and its disciplined capital deployment.

Marsh (MRSH) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, MRSH moved from a closing price of approximately $193.26 on August 26, 2026, to a closing price of $171.12 on September 25, 2026. That represents a decline of about 11.5%. The slide was broad-based rather than a single-session event, with the stock grinding lower through most of September.

The quarterly picture is more balanced. The stock began the third quarter near $172 in early July, rallied to an intra-quarter closing peak of $197.59 on July 29, and then gave back those gains through August and September. Measured from early July to late September, the shares are roughly flat to slightly lower, meaning nearly all of the recent decline has occurred within the most recent month. From the late-July peak, the stock is down roughly 13%.

What Drove MRSH Stock Price in the Last 30 Days

The recent weakness reflects a mix of fundamental headwinds and shifting sentiment rather than any single negative event. Marsh's second-quarter 2026 results, reported on July 21, actually beat expectations, with revenue up 6% to $7.4 billion and adjusted EPS up 9% to $2.96. The more recent selling has instead centered on pricing and margin concerns.

Commercial insurance and reinsurance pricing remains soft. According to the Marsh Global Insurance Market Index, primary commercial insurance rates fell 6% in the second quarter, an acceleration from a 5% decline in the first quarter, while global property rates declined 12% year over year. Reinsurance continues to experience a soft market driven by abundant capacity, and Guy Carpenter's revenue declined 2% in the quarter. Lower fiduciary interest income has added further pressure.

At the same time, total expenses rose 7% year over year, slightly outpacing revenue growth and contributing to a 20-basis-point decline in adjusted operating margin to 29.3%. Analysts have also highlighted valuation and balance-sheet considerations, noting a forward price-to-earnings multiple above the industry average and total debt of roughly $18.9 billion against about $1.7 billion in cash. These factors have encouraged profit-taking after the stock's strong mid-year run.

What Drove MRSH Stock Performance Over the Last Quarter

The broader three-month trend has been shaped by two competing narratives. Early in the quarter, positive earnings momentum, a 10% dividend increase to $0.99 per share announced in July, continued share repurchases, and strong consulting demand pushed the stock toward its late-July peak. Marsh Management Consulting grew 13% on an underlying basis in the second quarter, its fastest growth in more than two years, and Mercer delivered solid gains.

However, the risk and insurance side of the business faced persistent headwinds from declining commercial property rates, a soft reinsurance market, and lower fiduciary interest income. As these pressures became more visible and valuation concerns mounted, the stock's gains reversed. The result has been a quarter that started and ended near the same level, with a sharp rally in between and a pronounced pullback concentrated in the most recent month.

Trending AI Robots

Tickeron's Trending AI Robots page highlights a curated selection of AI-driven trading bots. Tickeron offers hundreds of AI trading bots that analyze thousands of tickers, but only the top-performing and most relevant bots appear in this section, making it easier for traders to identify strategies that are currently resonating with the market. The featured bots vary in strategy, timeframe, and performance metrics, spanning different asset types and trading styles to suit a range of objectives. For investors tracking names like MRSH and the broader insurance and consulting sector, the page offers a way to explore data-driven, automated approaches alongside traditional analysis.

MRSH Stock Forecast Drivers: What Investors Should Watch Next

Several factors are likely to shape MRSH's path in the months ahead. First, the company reports third-quarter 2026 results on October 15, 2026, which will provide updated commentary on insurance and reinsurance pricing, expense trends, and margin trajectory. Investors will also monitor whether commercial property rates stabilize and whether reinsurance conditions improve.

The "Thrive" program remains a key efficiency lever, with management targeting roughly $400 million in savings that are expected to be partly reinvested for growth. Capital deployment is another focal point, with the company guiding to approximately $5.5 billion deployed in 2026 across dividends, acquisitions, and buybacks. Pending acquisitions, including AltamarCAM and Alts Manager, are expected to close in the second half of 2026, subject to regulatory approval. Macroeconomic conditions, geopolitical risk, and the pace of insurance pricing recovery will continue to influence both the business and investor sentiment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations